Chemical Composition and Biological Activities of Methanolic Extract of Scrophularia Oxysepala Boiss

authors:

avatar Ardalan Pasdaran a , b , avatar Abbas Delazar c , avatar Seyed Abdulmajid Ayatollahi d , e , * , avatar Arsalan Pasdaran f

Medical Plant Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Pharmacognosy, School of Pharmacy, Research and Development Center of Plants and Medicinal Chemistry, Guilan University of Medical Sciences, Rasht, Iran
Department of Pharmacognosy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Pharmacognosy, School of
Faculty of Basic sciences, Central Tehran Branch, Islamic Azad University, Tehran, Iran.

How To Cite Pasdaran A, Delazar A, Ayatollahi S A, Pasdaran A. Chemical Composition and Biological Activities of Methanolic Extract of Scrophularia Oxysepala Boiss. Iran J Pharm Res. 2017;16(1):e124930. https://doi.org/10.22037/ijpr.2017.1975.

Abstract

Isolated five known iridoids glycosides (Scrophuloside A, Harpagoside B, 5-hydroxyloganin, 8-O-acetylharpagide and 6-O-methyl,1-glucopyranosyl catalpol), one phenyl ethanoid glycoside (Verbascoside) and a phenyl ethanol amine (2-(4-Chlorobenzyl amino) ethanol) compound from the methanolic extract of aerial parts of Scrophularia oxysepala using by high performance liquid chromatographyare based on isocratic and liner gradients by C18 column. The structure elucidations of the isolated compounds were performed by spectroscopic methods including1H-NMR, 13C-NMR, 2 D NMR technique such as HMBC( in deuterated methanol as solvent), GC-MS and UV, also methanolic extract and fractions( fractionated on solid phase extraction on C18 cartridge(Spack-C18)) of this plant was tested for free radical scavenging properties toward the 1, 1-diphenyl-1-picrylhydrazyl (DPPH), general toxicity (Brine shrimp toxicity assay) , insecticidal ( Contact toxicity insecticidal assay) and antimalarial activities (hemebiocrystallization inhibition assay).

Introduction

Natural chemical compounds presented as potent sources for new drug development. Among of the natural compounds, Iridoids and Iridoids like structure is a one of the significant phytochemical group structures that showed appropriate anti-parasitic potential in many investigations(1, 2). Similar structures are obvious in some important drugs such as Ivermectin as an important anti-parasitic drug. Parallel to this potential other activities such as radical scavenging and cytotoxic activity were detected in various Iridoids compounds(3-5).The Scrophulariaceae family consists of 220 genera known as the rich source of sugar esters and iridoid glycosides(6). The Scrophularia genus is represented by 60 species in the flora of Iran used as antipyretic, febrifuge and antibacterial, erythema, mouth dryness, constipation, prurigo, furunculosis, sore throat, ulcerous stomatitis, tonsillitis, and in the treatment of cancer (7). Previous investigations of Scrophulariaspecies led to the isolation and characterization of Iridoid glucosides from S.Buergeriana (8, 9) and S. ningpoensis(10) and phenylpropanoid glycosides from S. ningpoensis (11). Based on these researches Scrophularia genus considered as a brilliant source of various iridoid compounds (12). Therefore, we designed this investigation for identification of S. oxysepala compounds especially acylated iridoids for antimalarial activity and others bioactivity. In this paper, we described the isolation and structure determination of chemical compounds and some biological activities of methanolic extract of the aerial part of S. oxysepala.

Experimental

General

UV spectra were obtained in methanol in Shimadzu UV160-100. NMR spectra were recorded in CD3OD on a Bruker 200,400 MHz NMR spectrometer (200,400 MHz for1H and 200, 50 MHz for 13C) using residual solvent peak as the internal standard. Methanolic fractions were purified by a Knauer preparative HPLC coupled with UV-Visible–PDA detector (140-400 nm).

Plant material

The aerial parts of S. oxysepala were collected from East Azerbaijan province 30 kilometer to Kalibar town, Garehdagh mountain in the during flowering period. A voucher specimen (2821) has been deposited at the Herbarium of the Researches center for agriculture and natural resources, East Azerbaijan, Iran.

Extraction and isolation

The air-dried and powdered aerial parts of S. oxysepala (1800 g) were Soxhlet-extracted with n-hexane, dichloromethane (DCM), and methanol (MeOH) (2 L each). All these extracts were separately concentrated using a rotary evaporator at a maximum temperature of 45 °C.A portion of the MeOH extract (2 g) was subjected to solid phase extraction (SPE) on a Sep-Pak (10g) C18 cartridge using a step gradient of MeOH: water mixture (10:90, 20:80, 40:60, 60:40, 80:20, 100:0). The preparative HPLC (Dr. Mainsch GmbH ODS column 20 μM, 250 mm × 20 mm); liner gradient 0-45 min 20-90% methanol (MeOH) in water; isocratic gradient 90% MeOH in water during 45-50 min; liner gradient 50-52 min 90-100% MeOH in water; isocratic gradient 52-55 min 100 MeOH; liner gradient 55-58 min100-20% MeOH in water; isocratic gradient 20% MeOH in water during 58- 65 min; flow rate = 8 mL/min detection at 190- 400 nm to yielded: 2-(4-Chlorobenzyl amino) ethanol (8.2 mg, tR= 18.4 min) (1) from 10% MeOH SPE fraction, liner gradient 0-24 min 60-90% methanol in water; isocratic gradient 90% methanol in water during 20-40 min; liner gradient 40-43 min 90-100% MeOH in water; isocratic gradient 43-45 min 100% MeOH; liner gradient 45-47 min 100-60% MeOH; isocratic gradient 60% MeOH in water during 47-50 min; flow rate = 8 mL/min detection at 190-400 nm ) to yielded: Scrophuloside A (6.3mg , tR= 24.8 min)(13) (2), Harpagoside B (5.9 mg ,tR= 21.6 min)(14) (3) from 60% MeOH fraction, liner gradient 0-45 min30-80% methanol in water; isocratic gradient 80% methanol in water during 45-50 min; liner gradient 50-52 min 80-100% MeOH in water; isocratic gradient 52-58 min 100% MeOH; liner gradient 100-30% MeOH during 60-65 min; flow rate = 8 mL/min detection at 190- 400 nm to yielded Verbascoside (4.2 mg, tR= 19.1 min) (4), 5-hydroxyloganin (5.4 mg, tR=13.4 min) (5), 8-O-acetylharpagide (10.3 mg, tR= 21.2 min) (6) and 6-O-methyl,1-glucopyranosyl catalpol (13.6 mg, tR= 16.8 min) (7) from 40% MeOH fraction(Figure 1. Table 1, 2, 3).

Hemebiocrystallization inhibition assay (Antimalarial activity)

The potent antimalarial activity of methanolic extract and its fractions was evaluated by the method described by Fitch et.al. in 1999 with some modifications (15, 16). Briefly, different concentrations of methanolic extract and its fractions (0 to 3 mg/mL in 10% DMSO) were incubated with 300 μM of hematin (freshly dissolved in 0.1 M NaOH), 10 mM oleic acid and 10 μM HCl. The reaction volume was adjusted to 1 mL using 0.5 M sodium acetate buffer to obtain pH 5. Chloroquine diphosphate was used as a positive control. The samples were incubated overnight at 37 oC with regular shaking. After incubation, samples were centrifuged (14,000 g, 10 min, at 21 °C) and the hemozoin pellet repeatedly washed with sonication (30 min, at 21 °C; FS100 bath sonicator; Decon Ultrasonics Ltd.) by 2.5% (w/v) SDS in phosphate buffered saline followed by a final wash in 0.1 M sodium bicarbonate (pH 9.0) until the supernatant was clear (Usually 3-5 washes). After the final wash, the supernatant was removed and the pellets were re-suspended in 1 mL 0.1 M NaOH. The hemozoin content was determined by measuring the absorbance at 400 nm (BeckmannDU640 spectrophotometer) using a 1 cm quartz cuvette. The results were recorded as % inhibition (I %) of heme polymerization/crystallization compared to positive control (chloroquine) using the following equation: I% = [(AB–AA)/AB] × 100, where AB: absorbance of blank; AA: absorbance of test samples.

Free-radical-scavenging assay

The electron donation ability of the extracts was determined spectrophotometrically by the bleaching of purple colored methanolic solution of DPPH (2, 2-diphenyl-1-picrylhydrazyl) as a reagent. 2, 2-Diphenyl-1-picrylhydrazyl (C18H12N5O6) was obtained from Sigma-Aldrich (Germany). DPPH (4 mg) was dissolved in MeOH (50 mL) to obtain the concentration of 80 μg/mL. Methanolic extract and its fractions were dissolved in MeOH to obtain a concentration of 1 mg/mL. Dilutions were made to obtain concentrations of 0.25, 0.125, 0.0625, 0.03125, 0.015625, 0.0078125, 0.00390625, 0.001953125, 0.000976563, 0.000488281 mg/mL. Diluted solutions were mixed with DPPH (1 mL) and allowed to stand for 30 min for any reaction to occur. The UV absorbance of samples and blank was recorded at 517 nm. The experiment was performed in triplicate and the average absorption was noted for each concentration. The same procedure was followed as the positive control, Quercetin. Percent inhibition of the free radical DPPH (I %) was calculated in the following equation:

I% = [(AB–AA)/AB] × 100, where AB: absorbance of blank; AA: absorbance of test samples. Concentration providing 50% inhibition (RC50) was calculated from the graph plotting inhibition percentage against test sample concentrations (17, 18).

Contact toxicity insecticidal assay

Adults of Oryzeaphilus mercator were collected from a laboratory culture. O.mercator was reared on a mixture of whole wheat and maize flour at the ratio 1:1 (0.5 Kg). All insects were reared at 27 ± 2 °C, 12% moisture content and continuous darkness for about 3 weeks without exposing to insecticides. Adults used in the experiments were 1-3 week old and of mixed sex. Methanolic extract and its fractions were dissolved in a suitable solvent to obtain a concentration of 1, 5, 10 and 15 mg/mL. The control was treated with pure solvents. After the solvent evaporation, 10 adults of O.mercator (Silvanidae) were placed in 20 mL glass vials maintained at 27 ± 2 °C, 12% moisture content and 12 h photo phase. The experimental design was completely randomized, with three replicates. Insect mortality was evaluated after 4, 8, 24, 48 h of exposure. Responses to treated vial versus control were converted to «percentage of mortality»(19).

Brine shrimp toxicity assay

Preliminary toxicity activity of MeOH extract and its fractions were determined by brine shrimp lethality assay according to Meyer et al method (20). Brine shrimp eggs (Artemia salina) were hatched in artificial seawater (3.8% sodium chloride solution) under artificial light at 28 °C with full aeration. After incubating for 24 h, the nauplii were attracted to one side of the beaker with a light source and collected with a Pasteur pipette. The MeOH extract and its fractions were initially dissolved in methanol. Solvent was evaporated and diluted with artificial seawater to provide the required concentrations (0.195, 0.39, 0.78, 1.562, 3.156, 6.25, 12.5, 25, 50 and 100 mg/mL). 15 nauplii were added to each tube containing the sample. After 24 h, the number of survivors was counted and recorded. The percentage of mortality in each tube and control was determined using the equation: % Mortality = (number of dead nauplii/ initial number of live nauplii ) × 100%. Lethality concentration fifties (LC50) for the assay were determined from the percentage mortality against logarithm of concentration graph.

Results and discussion

The free-radical-scavenging activity of the MeOH extract and its fractions of the aerial parts of S.oxysepala was evaluated in-vitro by the DPPH assay. The hydrogen atoms or electrons donation ability of the extracts was determined spectrophotometrically by the bleaching of purple-colored methanolic solution of DPPH (2,2-diphenyl-1-picrylhydrazyl) as a reagent (17). The method is based on the reduction of methanolic DPPH solution in the presence of a hydrogen-donating scavenger through the formation of the non-radical form of DPPH (21).Tested extract and its fractions were capable to reduce the stable DPPH radical. A concentration-dependent activity pattern was observed (Table 4). Results of the brine shrimp cytotoxicity assay showed that 80% and 60% fractions showed mild cytotoxicity in comparison with podophyllotoxine as the standard (Table 4). These fractions have high content of acylated Iridoide glycosides. According to the previous research acylated Iridoide glycosides such as Scropolioside B and ScrospiosideA showed cytotoxicity (7).

Structures of isolated compounds from S.oxysepala
Table 1

1HNMR data of compounds 1-7.

1234567
δ Hδ Hδ Hδ Hδ Hδ Hδ H
1_4.89d(9.4)6.18d(1.5)_5.67d(1.4)5-5.26.08 brs
27.40*__6.70brs_--
37.40*6.42dd(1.4 ,6)6.44dd(1.5,6.4)_7.48s6.38 dd (1.6, 6)6.40 d (6.4)
4_5.04dd(6, 4.5)___5-5.25-5.2
57.40*2.51m_6.70d(8)_2.34-
67.40*4.09d(8)_6.59dd(1.6,8)3.94t(4.5)-3.9
73.94s3.79brs2.32d(15.2)2.83t(7.2)2.64,2.09dd(5.6,14)3.78 brs1.26-2.21
8___3.8-4.1*2.25m--
9_2.60dd(9.4,8)2.97d(1)_2.82*2.59 dd (1.6, 7.6)2.86 brs
10_4.20, 3.85d(13)1.5s_0.98d(7.2)3.85, 4.19 dd (13.2, 13.2)1.46 s
11-----3.49 s-
12------2.02 s
1'2.89t(5.4)4.83d(7.8)4.65d(7.9)4.40d(8)4.59d(7.9)4.81 d (7.6)4.61 d(7.8)
2'3.75t(5.4)__3.2-3.8*3.2-3.8*3.1-3.43.1-3.8
3'_3.46d(8.6)_3.2-3.8*3.2-3.8*3.1-3.43.1-3.8
4'_3.42_4.1-4.8**3.2-3.8*3.1-3.43.1-3.8
5'_3.53m_3.2-3.8*3.2-3.8*3.1-3.43.1-3.8
6'___3.2-3.8*3.94,3.70dd(10,1.5)3.68, 3.94 dd (12, 12)3.1-3.8
1''_4.97d(1.5)___--
2''_5.31_7.06d(1.8)_--
3''_5.39 d(9.6)___--
4''_5.16dd(10, 9.6)___--
5''___6.84d(8)_--
6''_1.21d(6)_6.98dd(1.8,8)_--
7''__7.72d(16)7.64d(16)_--
8''_2.10s6.56d(16)6.32d(16)_--
9''_____--
10''_1.99s___--
1'''___5.19d(1.5)_--
2'''_7.48*m_3.2-3.8*_--
3'''_7.34*m_3.2-3.8*_--
4'''_7.34*m_3.2-3.8*_--
5'''_7.34*m_3.2-3.8*_--
6'''_7.48*m_1.11d(6)_--
7'''_7.69d(16)___--
8'''_6.48d(16)___--
9'''_____--
O-CH3__3.369s_3.73s--
Table 2

13CNMR data of compounds 1-7.

1234567
δCδCδCδCδCδCδC
1135.093.7293.21130.0094.1193.9491.07
2128.42__113.76_--
3130.43141.09142.56144.71153.18140.65142.45
4133.53101.76105.44143.26_102.62105.45
5130.4335.73_115.6846.2935.9373.11
6128.4283.4276.20119.8370.2987.0376.25
749.6557.9944.8335.1542.0956.8744.60
8_65.1487.3970.9288.465.3587.22
9_41.8554.13_48.2441.7054.03
10_59.9821.24_17.4161.2720.79
1151.2198.2998.59101.6398.2458.05-
1258.7273.4173.1374.7872.95-21.07
1'_77.2376.2080.2576.4398.2798.49
2'_70.8572.0569.1170.2073.2871.91
3'_76.2576.7574.6077.0476.9776.25
4'_61.5761.5160.9361.4170.1370.25
5'_96.25134.35126.20_76.0976.76
6'_69.35127.81113.76_60.0261.40
1''_70.37128.62145.42_--
2''_68.89130.12148.39_--
3''_66.63128.62115.68_--
4''_16.30127.81121.82_--
1234567
5''_170.21144.72146.61_--
6''_19.33118.69115.08_--
7''_170.43167.34166.87_--
8''_19.33___--
9''_130.41_102.77_--
10''_128.00_70.92_--
1'''_128.67_70.60_--
2'''_134.07_72.35_--
3'''_128.67_69.11_--
4'''_128.00_17.05_--
5'''_145.97___--
6'''_116.48___--
7'''_165.82___--
8'''__49.79_50.09--
9'''--
O-CH3--
Table 3

HMBC data of compound 2

1H-NMR13C-NMRHMBC
2JCH3JCH
δ HδC
14.89d(9.4)93.72C-9C-1ʹ, C-8
2____
36.42dd(1.4 ,6)141.09__
45.04dd(6, 4.5)101.76C-3_
52.51m35.73__
64.09d(8)83.42C-5 , C-7C-8 , C-1ʹ
73.65brs57.99C-6C-5
8_65.14__
92.60dd(9.4,8)41.85__
104.20, 3.85d(13)59.98__
1'4.83d(7.8)98.29__
2'_73.41__
3'3.46d(8.6)77.23__
4'3.4270.85__
5'3.53m76.25__
6'_61.57__
1''4.97d(1.5)96.25C-2 ʹʹC-3 ʹʹ , C-5 ʹʹ , C-6
2''5.3169.35C-3 ʹʹC-7 ʹʹ , C-4 ʹʹ
3''5.39 d(9.6)70.37C-2 ʹʹ, C-4 ʹʹC-9ʹʹʹ
4''5.16dd(10, 9.6)68.89C-3 ʹʹ , C-5 ʹʹC-9 ʹʹ
1H-NMR13C-NMRHMBC
5''_66.63__
6''1.21d(6)16.30__
7''_170.21__
8''2.10s19.33C-7 ʹʹʹ_
9''_170.43__
10''1.99s19.33C-9 ʹʹʹ_
1'''_130.41__
2'''7.48*m128.00C-3 ʹʹʹC-7 ʹʹʹ, C-4 ʹʹʹ
3'''7.34*m128.67C-4 ʹʹʹ, C-2 ʹʹʹ_
4'''7.34*m134.07C-5ʹʹʹC-2 ʹʹʹ
5'''7.34*m128.67C-4 ʹʹʹ, C-6 ʹʹʹ_
6'''7.48*m128.00C-5ʹʹʹC-7 ʹʹʹ
7'''7.69d(16)145.97C-9 ʹʹʹ, C-8 ʹʹʹC-2 ʹʹʹ
8'''6.48d(16)116.48C-9 ʹʹʹC-1 ʹʹʹ
9'''_165.82__
Table 4

Free-radical-scavenging and cytotoxic activity of methanolic extract and its fractions of S .oxysepala

SampleBrine shrimp toxicityAntioxidant activity
LC50(µg/mL)RC50(mg/mL)
MeOH extract641.140.957
10% Fraction835.680.247
20% Fraction768.200.137
40% Fraction503.320.0247
60% Fraction201.040.0438
80% Fraction419.360.640
100% Fraction512.610.825
StandardPodophyllotoxine 2.58Quercetin 0.0249
Table 5

Contact toxicity assay of the fractions and MeOH extract of S.oxysepala

HoursConc.(mg/mL)MeOH extract40 % fraction60 % fraction
% Mortality% Mortality% Mortality
41000
53.300
1003.30
153.33.310
813.33.33.3
503.310
103.36.610
153.31020
2416.63.310
53.36.610
106.61020
153.31020
4816.63.310
5101020
10101030
156.61030

Malaria-infected erythrocytes are characterized by a high rate of production of ferriprotoporphyrin IX (heme) as a result of the ingestion and digestion of host cell hemoglobin (22). Parasite utilizes hemoglobin as food source during intra erythrocytes development and proliferation (23). Released heme is a toxic compound (24). For the detoxification of heme, crystals of hemozoin in the food vacuoles of malaria parasites are formed that commonly known as malaria pigment (25-27). Chloroquine and most of other antimalarial compounds inhibit β-hematin formation under different conditions (26). The hemebiocrystallization inhibition assay is based on inhibition of β-hematin formation (28, 29).In this study the MeOH extract and its fractions of S. oxysepala were assessed for potential antimalarial activity by the hemebiocrystallization inhibition assay. The 80% and 60% fractions showed significant antimalarial effects compared to other fractions and blank. At 1-2 mg/mL concentrations heme biocrystallization inhibition was higher than the blank. The IC50 values of 80% and 60% fractions were 0.936 and 0.754 mg/mL while the IC50 of positive control (chloroquine) was 0.052 mg/mL. This is the first report on the insecticidal property of the S. oxysepala that were evaluated by contact toxicity assay. The results showed that 40% and 60% fractions had potent insecticidal activity compared to other fractions (Table 5).

Acknowledgements

References

  • 1.

    Tandon J, Srivastava V, Guru P. Iridoids: a new class of leishmanicidal agents from Nyctanthes arbortristis. J. Nat. Prod. 1991;54:1102-4. [PubMed ID: 1791475].

  • 2.

    Castillo D, Arevalo J, Herrera F, Ruiz C, Rojas R, Rengifo E, Vaisberg A, Lock O, Lemesre JL, Gornitzka H, Sauvain M. Spirolactone iridoids might be responsible for the antileishmanial activity of a Peruvian traditional remedy made with Himatanthus sucuuba (Apocynaceae). J. Ethnopharmacol. 2007;112:410-14. [PubMed ID: 17459622].

  • 3.

    Saracoglu I, Harput US. In-vitro cytotoxic activity and structure activity relationships of iridoid glucosides derived from Veronica species. Phytother. Res. 2012;26:148-52. [PubMed ID: 21678519].

  • 4.

    Lin S, Shen YH, Li HL, Yang XW, Chen T, Lu LH, Huang ZH, Liu RH, Xu XK, Zhang WD, Wang H. Acylated iridoids with cytotoxicity from Valeriana jatamansi. J. Nat. Prod. 2009;72:650-55. [PubMed ID: 19245261].

  • 5.

    Cuendet M, Hostettmann K, Potterat O, Dyatmiko W. Iridoid glucosides with free radical scavenging properties from Fagraea blumei. Helv. Chim. Acta. 1997;80:1144-52.

  • 6.

    Boros CA, Stermitz FR. Iridoids, an updated review. Part I. J. Nat. Prod. 1990;53:1055-147.

  • 7.

    Nguyen AT, Fontaine J, Malonne H, Claeys M, Luhmer M, Duez P. A sugar ester and an iridoid glycoside from Scrophularia ningpoensis. Phytochem. 2005;66:1186-91.

  • 8.

    Kim SR, Lee KY, Koo KA, Sung SH, Lee NG, Kim J, et al. Four new neuroprotective iridoid glycosides from Scrophularia buergeriana roots. J. Nat. Prod. 2002;65:1696-9. [PubMed ID: 12444706].

  • 9.

    Lin SJ, Jiang SH, Li YM, Zeng JF, Zhu DY. Two novel iridoids from Scrophularia buergeriana. Tetrahedron Lett. 2000;41:1069-71.

  • 10.

    Qian J, Hunkler D, Rimpler H. Iridoid-related aglycone and its glycosides from Scrophularia ningpoensis. Phytochem. 1992;31:905-11.

  • 11.

    Li YM, Jiang SH, Gao WY, Zhu DY. Phenylpropanoid glycosides from Scrophularia ningpoensis. Phytochem. 2000;54:923-25.

  • 12.

    Tundis R, Loizzo MR, Menichini F, Statti GA, Menichini F. Biological and pharmacological activities of iridoids: recent developments. Mini Rev. Med. Chem. 2008;8:399. [PubMed ID: 18473930].

  • 13.

    Stavri M, Mathew KT, Gibbons S. Antimicrobial constituents of Scrophularia deserti. Phytochem. 2006;67:1530-33.

  • 14.

    Ahmed B, Al-Rehaily AJ, Al-Howiriny TA, El-Sayed KA, Ahmad MS. Scropolioside-D2 and harpagoside-B: two new iridoid glycosides from Scrophularia deserti and their antidiabetic and antiinflammatory activity. Biol. Pharm. Bull. 2003;26:462-7. [PubMed ID: 12673026].

  • 15.

    Fitch CD, Cai GZ, Shoemaker JD. A role for linoleic acid in erythrocytes infected with Plasmodium berghei. Biochim. Biophys. Acta. 2000;1535:45-49. [PubMed ID: 11113630].

  • 16.

    Tripathi AK, Khan SI, Walker LA, Tekwani BL. Spectrophotometric determination of de-novo hemozoin/β-hematin formation in an in-vitro assay. Anal. Biochem. 2004;325:85-91. [PubMed ID: 14715288].

  • 17.

    Takao T, Kitatani F, Watanabe N, Yagi A, Sakata K. A simple screening method for antioxidants and isolation of several antioxidants produced by marine bacteria from fish and shellfish. Nat. Prod. 1994;58:1780-83.

  • 18.

    Delazar A, Biglari F, Esnaashari S, Nazemiyeh H, Talebpour AH, Nahar L, Sarker SD. GC-MS analysis of the essential oils, and the isolation of phenylpropanoid derivatives from the aerial parts of Pimpinella aurea. Phytochem. 2006;67:2176-81.

  • 19.

    Isman MB, Proksch P, Yan JY. Insecticidal chromenes from the Asteraceae: structure-activity relations. Entomol. Exp. Appl. 1987;43:87-93.

  • 20.

    Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL. Brine shrimp: a convenient general bioassay for active plant constituents. Planta Med. 1982;45:31-34.

  • 21.

    Kumarasamy Y, Byres M, Cox PJ, Jaspars M, Nahar L, Sarker SD. Screening seeds of some Scottish plants for free radical scavenging activity. Phytother. Res. 2007;21:615-21. [PubMed ID: 17357975].

  • 22.

    Famin O, Krugliak M, Ginsburg H. Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs. Biochem. Pharmacol. 1999;58:59-68. [PubMed ID: 10403519].

  • 23.

    Francis SE, Sullivan DJ Jr. and Goldberg DE. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 1997;51:97-123.

  • 24.

    Tripathi AK, Gupta A, Garg SK, Tekwani BL. In-vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials. Life Sci. 2001;69:2725-33. [PubMed ID: 11720077].

  • 25.

    Kalkanidis M, Klonis N, Tilley L, Deady LW. Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of β-haematin. Biochem. Pharmacol. 2002;63:833-42. [PubMed ID: 11911834].

  • 26.

    Egan TJ, Ncokazi KK. Quinoline antimalarials decrease the rate of beta-hematin formation. J. Inorg. Biochem. 2005;99:1532-9. [PubMed ID: 15927260].

  • 27.

    Rathore D, Jani D, Nagarkatti R, Kumar S. Heme detoxification and antimalarial drugs – Known mechanisms and future prospects. Drug Discov. Today Ther. Strat. 2006;3:153-58.

  • 28.

    Fitch CD, Cai GZ, Chen YF, Shoemaker JD. Involvement of lipids in ferriprotoporphyrin IX polymerization in malaria. Biochim. Biophys. Acta. 1999;1454:31-7. [PubMed ID: 10354512].

  • 29.

    Tripathi AK, Khan SI, Walker LA, Tekwani BL. Spectrophotometric determination of de-novo hemozoin/beta-hematin formation in an in-vitro assay. Anal. Biochem. 2004;325:85-91. [PubMed ID: 14715288].